11th July 2013: BK652 ink rises above operational challenges with drying time of less than half a second.
Domino Printing Sciences today announces the launch of its new ink in response to the emerging requirements of the pharmaceutical sector. The BK652 ink was developed by Domino’s ink specialists to be ultra-fast drying, enabling manufacturers to meet the regulatory requirements of item level serialisation whilst maintaining line speeds and reducing ink dry time by in excess of 50%. The ink also displayed exceptional lightfastness in independent tests, retaining readability after exposure to light equivalent of Blue Wool 6 and showing four times more resistance to fade than typical inks used in retail packaging.
The new ink is available now for use with Domino’s G-Series Thermal Ink Jet range, which prints high-definition coding onto a variety of pharmaceutical substrates including cartons, sachets, pouches, labels and blister packs. The unique multi-substrate G-Series printers can print bar codes, 2D codes, human readable information and graphics onto a variety of both porous and non porous surfaces.
BK652 ink’s market leading dry time enables data and codes to be completely fixed and bonded in record time without impeding on the productivity of the rest of the packaging line. Cartons with data printed using BK652 can be picked up in the second and third operations on the line much quicker, meaning that operational efficiency is increased significantly. It is also very high-contrast for good legibility by machine vision systems, therefore maintaining continuously running lines and reducing on line reject rates.
“We anticipate that BK652 will build on the success that we have already seen in this sector with BK651. Our in-house ink development team re-formulated this product in light of the legislative requirements we see in Europe and the US. The super-fast dry time combined with excellent de-cap time will reduce the initial rejects manufacturers see after the machine has been idle, thus cutting reworking requirements. The application of tamper evident labelling for example is also made possible almost immediately with no risk of smudging,” explains Alan Mutch, product manager for thermal ink jet at Domino.
“The Falsified Medicines Directive places new emphasis on code quality beyond the point of manufacture. Under the legislation pharmaceutical product will be authenticated at the point of dispensation, making long term ink lightfastness and contrast vitally important, even after what could be years in the supply chain. Simply, if a code cannot be scanned before it reaches the patient or consumer the product will likely be scrapped” adds Craig Stobie, global life sciences sector manager at Domino. “BK652 has been developed with these challenges in mind and we have received exceptional results from independent testing and excellent feedback from manufacturer trial sites.”
Posted on Monday 18th November 2013